Firefly Neuroscience
AIFF
22 hedge funds and large institutions have $802K invested in Firefly Neuroscience in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
10% more funds holding
Funds holding: 20 → 22 (+2)
0.01% more ownership
Funds ownership: 0.1% → 0.11% (+0.01%)
65% less capital invested
Capital invested by funds: $2.29M → $802K (-$1.49M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $27K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$119K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$116K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$103K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$93.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$69.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$96K |
| 2 |
SPM
Symmetry Peak Management
Radnor,
Pennsylvania
|
-$92K |
| 3 |
VF
Virtu Financial
New York
|
-$55.7K |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$26K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12.7K |
AIFF Hedge Fund Activity: Q2 2022 in Review
22 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Firefly Neuroscience (AIFF) for Q2 2022, worth a combined $802K — down 65% from $2.29M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new AIFF positions and 4 closed out — a net gain of 2 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $119K. The largest seller was Jane Street, exiting entirely with an estimated $96K sold.
- 22 institutional investors held Firefly Neuroscience (AIFF) as of Q2 2022, up from 20 in Q1 2022.
- Funds reported $802K of Firefly Neuroscience stock for Q2 2022, down 65% quarter-over-quarter.
- 6 funds opened new Firefly Neuroscience positions in Q2 2022 and 4 closed out, a net change of +2 holders.
- The largest Firefly Neuroscience buyer in Q2 2022 was BlackRock, an estimated $119K added.
- The largest Firefly Neuroscience seller in Q2 2022 was Jane Street, an estimated $96K sold.
Based on aggregated 13F filings for Q2 2022.